The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting
Biochemical Society Transactions · 26.08.2026 · 54 (8) · 1079-1094
DOI: 10.1042/bst20260001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 07.08.2026. Verfasst von Beatriz Magalhães Gomes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Comparative and Translational Oncology, Department of Veterinary Medicine, School of Animal Science and Food Engineering, Universidade …. Hauptthemen laut MEDLINE: Tumor Microenvironment, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).
Abstract (Originalsprache)
Pancreatic cancer, predominantly represented by Pancreatic Ductal Adenocarcinoma (PDAC), is one of the most frequent and deadly types of cancer. In contrast with other types of cancer, for which advances in prevention, early detection, and treatment have contributed to decreasing incidence and mortality, PDAC continues to be rarely diagnosed at early stages of the disease and exhibits a poor prognosis. As a consequence, therapeutic efficacy remains limited, which is reflected in high mortality. Therefore, the development of novel and effective therapeutic strategies against PDAC is urgent. However, a major component limiting therapeutic efficacy is the highly complex PDAC tumor microenvironment (TME), which is composed of cancer-associated fibroblasts, immunosuppressive cells, cancer stem cells, and a dense extracellular matrix, a structural and biochemical scaffold that sustains tumor development and influences several PDAC phenotypes including metabolism, immune infiltration, metastasis, and therapeutic response. The present review focuses on and discusses the key components of the PDAC TME, with particular emphasis on ECM remodeling, stromal components, their impact on tumor progression and therapeutic resistance, and emerging strategies to target these processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Comparative and Translational Oncology, Department of Veterinary Medicine, School of Animal Science and Food Engineering, Universidade de São Paulo (USP), Pirassununga, Brazil.
ORCID-Profile: Beatriz Magalhães Gomes, Pedro Luiz Porfirio Xavier
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Zitieren
APA
Gomes, B. M., & Xavier, P. L. P. (2026). The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting. Biochemical Society Transactions, 54(8), 1079-1094. https://doi.org/10.1042/bst20260001
Vancouver
Gomes BM, Xavier PLP. The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting. Biochemical Society Transactions. 2026;54(8):1079-1094. doi:10.1042/bst20260001
BibTeX
@article{Gomes2026,
author = {Gomes, Beatriz Magalhães and Xavier, Pedro Luiz Porfirio},
title = {The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting},
journal = {Biochemical Society Transactions},
year = {2026},
volume = {54},
number = {8},
pages = {1079--1094},
doi = {10.1042/bst20260001}
}
EUVIMED